Archive for the ‘Columbia spinoffs’ Category

bluebird bio (Columbia) Awarded $269k and Commits to Creating 10 Jobs (01/03/2011)

April 11, 2011

bluebird bio is a Columbia spinoff developing innovative gene therapies for severe genetic disorders. The company was founded by Dr. Arthur Bank, who was Head of the Division of Hematology at Columbia-Presbyterian Medical Center.

From the company’s press release:
The Massachusetts Life Sciences Center has approved $23.9 million in 2010 tax incentives to encourage growth at 30 life sciences companies. The recipient companies have committed to creating nearly 1000 new jobs in 2011. Among them are ten companies based in Cambridge that will receive a combined total of over $9.6 million in tax incentives. The Cambridge companies have committed to the creation of 451 jobs in 2011. read full press release

Advertisements

Schrödinger (Columbia) Acquires Synaptic Science (12/17/2010)

January 4, 2011

Schrödinger is a Columbia University spinoff focusing on chemical simulations for research in the pharmaceutical and biotechnology industries.

From the company’s press release:
Schrödinger announced today that it has acquired Synaptic Science, LLC. Synaptic Science’s award winning enterprise informatics platform, SEURAT™, has been adopted by a number of pharmaceutical and biotechnology companies. read full press release

RSoft (Columbia, UIUC, UCSB) Releases OptSim 5.2 (12/14/2010)

December 17, 2010

RSoft Design Group creates software tools for use in optical communications, optoelectronics, and electromagnetic modeling. Founded in 1990, the company has started licensing technology from Columbia University in 1993, and from UCSB and UIUC in 1997.

From the company’s press release:
RSoft Design Group, the leader in Photonics Design Automation software, announced the release of its award winning Optical Communication Design Suite version 5.2, which includes OptSim and its multimode companion ModeSYS. The new release includes cutting-edge features to design and simulate next generation systems such as 100 Gbit/s coherent PM-QPSD, Polarization induced all-optical switching systems, Bi-directional Ethernet in the First Mile (EFM) system, Interferometry based systems, Multimode systems with mode-coupling effects, and Plastic Optical Fiber systems. read full press release

bluebird bio (Columbia) and Généthon Announce Manufacturing Research Collaboration Centered on Lentiviral Vectors for Gene Therapy (12/14/2010)

December 17, 2010

bluebird bio is a Columbia spinoff developing innovative gene therapies for severe genetic disorders. The company was founded by Dr. Arthur Bank, who was Head of the Division of Hematology at Columbia-Presbyterian Medical Center.

From the company’s press release:
Cambridge, Mass. and Evry, France, December 14, 2010 – bluebird bio (formerly Genetix Pharmaceuticals Inc.), an emerging leader in the development of innovative gene therapies for severe genetic disorders, and Généthon, a leader in the field of gene therapy treatments for rare diseases, today announced a research collaboration focused on process development and scale up efforts for the manufacturing of lentiviral vectors. This agreement is designed to enable substantial advances in existing manufacturing process for the benefit of both partners. It will also strengthen bluebird bio’s manufacturing platform to enable robust, commercial-scale manufacturing and broaden the company’s capabilities in Europe. Specific terms of the agreement were not disclosed. read full press release

Nanosys (Caltech, Columbia) Partners with SEMATECH to Develop Flash Memory Technologies (12/7/2010)

December 13, 2010

Nanosys, Inc. , delivers process-ready materials for electronics device manufacturers and lithium ion battery makers. the company’s scientific co-founders include: UC Berkeley professor Dr. Paul Alivisatos, MIT professor Dr. Moungi Bawendi, Caltech professor Dr. James Heath, and UC Berkeley professor Dr. Peidong Yang.

From the company’s press release:
SEMATECH today announced that Nanosys, Inc., an advanced materials architect, has joined its Front End Processes (FEP) program, and will work with SEMATECH to develop new materials and processing techniques for extending flash memory technologies. read full press release

Lidl Enters into MPEG-2 License with MPEG LA (Columbia) (12/1/2010)

December 13, 2010

MPEG LA licenses patent pools for standards and other technology platforms on behalf of Columbia University and a number of commercial companies.

From the company’s press release:
MPEG LA, LLC, world leader in alternative one-stop patent licenses, today announced that Lidl Stiftung & Co. KG, Lidl Dienstleistung GmbH & Co. KG and affiliates (“Lidl”) have entered into the MPEG-2 Patent Portfolio License offered by MPEG LA. Under the License with MPEG LA, Lidl is responsible for paying royalties on its own branded MPEG-2 products. read full press release

Sigma-Aldrich and Nanosys (Caltech, Columbia) Enter into Distribution Agreement to Supply Materials to the Research Community (11/29/2010)

December 13, 2010

Nanosys, Inc., delivers process-ready materials for electronics device manufacturers and lithium ion battery makers. the company’s scientific co-founders include: UC Berkeley professor Dr. Paul Alivisatos, MIT professor Dr. Moungi Bawendi, Caltech professor Dr. James Heath, and UC Berkeley professor Dr. Peidong Yang.

From the company’s press release:
Sigma-Aldrich (Nasdaq: SIAL) today announced a distribution agreement with Nanosys, Inc., an advanced materials architect. Under the agreement, Sigma-Aldrich, through its Aldrich Materials Science business, is now distributing Nanosys-created silicon nanowires to the global scientific research community for the development of new applications in technologies such as solid-state lighting, electronics and energy storage. read full press release

Court Dismisses with Prejudice Nero AG’s Antitrust Claim Against MPEG LA (Columbia) (11/29/2010)

December 13, 2010

MPEG LA licenses patent pools for standards and other technology platforms on behalf of Columbia University and a number of commercial companies.

From the company’s press release:
The US District Court for the Central District of California dismissed for a second time last week a Sherman Act Section 2 claim brought by Nero AG against MPEG LA, this time with prejudice. read full press release

Medion Enters into MPEG LA’s (Columbia) MPEG-2 License (11/18/2010)

December 12, 2010

MPEG LA licenses patent pools for standards and other technology platforms on behalf of Columbia University and a number of commercial companies.

From the company’s press release:
MPEG LA announced today that Medion AG has entered into the MPEG-2 Patent Portfolio License offered by MPEG LA.

As a result of this agreement, several companies that license their essential MPEG-2 patents through MPEG LA have withdrawn patent enforcement actions pending before the District Court Düsseldorf, Germany. read full press release

Biosof LLC (Columbia) Awarded Qualifying Therapeutic Discovery Projects (QTDP) Grant (11/9/2010)

November 12, 2010

Biosof develops commercial software for life scientists in the biopharmaceutical industry. The company was spun out of Columbia University in 2004.

From the company’s press release:
Biosof LLC, software developer and service provider to the life sciences and health care industries, announced that the Federal government awarded it a grant to support the continuation of the development of Biosof’s PubSeq scientific knowledge search engine. The award was made through the Qualifying Therapeutic Discovery Projects Grant Program (QTDP). QTDP grants are being provided under section 48D of the Internal Revenue Code, enacted as part of the Patient Protection and Affordable Care Act of 2010. read full press release